Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Lamarca

Showing results (111-120 of 201) with videos related to

Pageof 21
Sort By:
Journal of Clinical Medicine|October 9, 2019
Follow-Up Recommendations after Curative Resection of Well-Differentiated Neuroendocrine Tumours: Review of Current Evidence and Clinical PracticeAngela Lamarca, Hamish Clouston, Jorge Barriuso, et al.
JHEP Reports : Innovation in Hepatology|March 26, 2026
Advanced: post-hoc analysis of the ABC-01, -02 and -03 clinical trialsAngela Lamarca, Paul Ross, Harpreet S Wasan, et al.
Future Oncology (London, England)|January 12, 2024
Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumorsChanghoon Yoo, Angela Lamarca, Hye Jin Choi, et al.
Neuroendocrinology|October 29, 2019
High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine TumorsJohan Botling, Angela Lamarca, Duska Bajic, et al.
Journal of the National Cancer Institute|May 12, 2019
Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical TrialsAngela Lamarca, Paul Ross, Harpreet S Wasan, et al.
Cancers|July 26, 2020
Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)Vera G Megdanova-Chipeva, Angela Lamarca, Alison Backen, et al.
Cancer Treatment Reviews|July 12, 2021
Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysisJulien Edeline, Angela Lamarca, Mairéad G McNamara, et al.
Cancer Treatment Reviews|November 5, 2023
Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinomaAngela Lamarca, Lorena Ostios, Mairéad G McNamara, et al.
Cancers|June 10, 2023
Third-Line Palliative Systemic Therapy for Advanced Biliary Tract Cancer: Multicentre Review of Patterns of Care and OutcomesSimon Gray, Octave Letissier, Constance d'Abrigeon, et al.
Expert Review of Gastroenterology & Hepatology|June 21, 2018
Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational studyAngela Lamarca, Lynne McCallum, Christina Nuttall, et al.
Pageof 21

Showing results (111-120 of 201) with videos related to

Sort By:
Pageof 21
Journal of Clinical Medicine|October 9, 2019
Follow-Up Recommendations after Curative Resection of Well-Differentiated Neuroendocrine Tumours: Review of Current Evidence and Clinical PracticeAngela Lamarca, Hamish Clouston, Jorge Barriuso, et al.
JHEP Reports : Innovation in Hepatology|March 26, 2026
Advanced: post-hoc analysis of the ABC-01, -02 and -03 clinical trialsAngela Lamarca, Paul Ross, Harpreet S Wasan, et al.
Future Oncology (London, England)|January 12, 2024
Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumorsChanghoon Yoo, Angela Lamarca, Hye Jin Choi, et al.
Neuroendocrinology|October 29, 2019
High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine TumorsJohan Botling, Angela Lamarca, Duska Bajic, et al.
Journal of the National Cancer Institute|May 12, 2019
Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical TrialsAngela Lamarca, Paul Ross, Harpreet S Wasan, et al.
Cancers|July 26, 2020
Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)Vera G Megdanova-Chipeva, Angela Lamarca, Alison Backen, et al.
Cancer Treatment Reviews|July 12, 2021
Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysisJulien Edeline, Angela Lamarca, Mairéad G McNamara, et al.
Cancer Treatment Reviews|November 5, 2023
Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinomaAngela Lamarca, Lorena Ostios, Mairéad G McNamara, et al.
Cancers|June 10, 2023
Third-Line Palliative Systemic Therapy for Advanced Biliary Tract Cancer: Multicentre Review of Patterns of Care and OutcomesSimon Gray, Octave Letissier, Constance d'Abrigeon, et al.
Expert Review of Gastroenterology & Hepatology|June 21, 2018
Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational studyAngela Lamarca, Lynne McCallum, Christina Nuttall, et al.
Pageof 21